Global Porcine Epidemic Diarrhea Vaccines Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by factors such as increasing demand for pork and pork products, rising awareness about animal welfare and safety standards, and growing demand for organic meat products.
Live vaccines segment accounted for the largest share of the global porcine epidemic diarrhea vaccines market in 2018 due to their ability to provide long-term immunity against porcine epidemic diarrhea virus (PEDV). Live vaccines are also preferred over killed vaccines because they do not require refrigeration or freezing which makes them more convenient than killed vaccine in developing countries where electricity supply is unreliable.
- Increasing demand for pork meat in emerging economies such as China and India is expected to drive the growth of the Porcine Epidemic Diarrhea Vaccines market.
- The increasing number of pig farms in China and India are also expected to fuel the growth of the Porcine Epidemic Diarrhea Vaccines market.
- Increasing awareness about animal welfare among consumers is also driving the growth of this market.
- The increasing demand for pork meat in emerging economies such as China and India is expected to drive the growth of this market.
Industry Growth Insights published a new data on “Porcine Epidemic Diarrhea Vaccines Market”. The research report is titled “Porcine Epidemic Diarrhea Vaccines Market research by Types (Live Vaccines, Killed Vaccines), By Applications (Piglets, Adults Pigs), By Players/Companies CAVAC, Green Cross Veterinary Products, Harrisvaccines, Inc., Komipharm, Nisseiken Co., Ltd., Qilu Animal Health, Zoetis”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Porcine Epidemic Diarrhea Vaccines Market Research Report
By Type
Live Vaccines, Killed Vaccines
By Application
Piglets, Adults Pigs
By Companies
CAVAC, Green Cross Veterinary Products, Harrisvaccines, Inc., Komipharm, Nisseiken Co., Ltd., Qilu Animal Health, Zoetis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Porcine Epidemic Diarrhea Vaccines Market Report Segments:
The global Porcine Epidemic Diarrhea Vaccines market is segmented on the basis of:
Types
Live Vaccines, Killed Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Piglets, Adults Pigs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CAVAC
- Green Cross Veterinary Products
- Harrisvaccines, Inc.
- Komipharm
- Nisseiken Co., Ltd.
- Qilu Animal Health
- Zoetis
Highlights of The Porcine Epidemic Diarrhea Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Live Vaccines
- Killed Vaccines
- By Application:
- Piglets
- Adults Pigs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Porcine Epidemic Diarrhea Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Porcine epidemic diarrhea vaccines are a type of vaccine that helps protect people from getting sick from porcine epidemic diarrhea (PED). PED is a highly contagious disease caused by the bacterium Porcine Reproductive and Respiratory Syndrome (PRRS), which can be deadly to pigs.nnThere are currently two types of porcine epidemic diarrhea vaccines available in the United States: an injectable vaccine and a nasal spray vaccine. Both vaccines help protect people against getting sick from PED, but there is some difference between them in how well they work. The injectable vaccine works best for protecting people who get vaccinated soon after being exposed to the virus, while the nasal spray vaccine works better for protecting people who are not likely to come into contact with infected pigs.
Some of the major players in the porcine epidemic diarrhea vaccines market are CAVAC, Green Cross Veterinary Products, Harrisvaccines, Inc., Komipharm, Nisseiken Co., Ltd., Qilu Animal Health, Zoetis.
The porcine epidemic diarrhea vaccines market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Porcine Epidemic Diarrhea Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Porcine Epidemic Diarrhea Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Porcine Epidemic Diarrhea Vaccines Market - Supply Chain
4.5. Global Porcine Epidemic Diarrhea Vaccines Market Forecast
4.5.1. Porcine Epidemic Diarrhea Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Porcine Epidemic Diarrhea Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Porcine Epidemic Diarrhea Vaccines Market Absolute $ Opportunity
5. Global Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Type
5.3.1. Live Vaccines
5.3.2. Killed Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Application
6.3.1. Piglets
6.3.2. Adults Pigs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Porcine Epidemic Diarrhea Vaccines Demand Share Forecast, 2019-2026
9. North America Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Application
9.4.1. Piglets
9.4.2. Adults Pigs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Type
9.7.1. Live Vaccines
9.7.2. Killed Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Porcine Epidemic Diarrhea Vaccines Demand Share Forecast, 2019-2026
10. Latin America Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Application
10.4.1. Piglets
10.4.2. Adults Pigs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Type
10.7.1. Live Vaccines
10.7.2. Killed Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Porcine Epidemic Diarrhea Vaccines Demand Share Forecast, 2019-2026
11. Europe Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Application
11.4.1. Piglets
11.4.2. Adults Pigs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Type
11.7.1. Live Vaccines
11.7.2. Killed Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Porcine Epidemic Diarrhea Vaccines Demand Share, 2019-2026
12. Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Application
12.4.1. Piglets
12.4.2. Adults Pigs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Type
12.7.1. Live Vaccines
12.7.2. Killed Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Porcine Epidemic Diarrhea Vaccines Demand Share, 2019-2026
13. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Application
13.4.1. Piglets
13.4.2. Adults Pigs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size and Volume Forecast by Type
13.7.1. Live Vaccines
13.7.2. Killed Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Porcine Epidemic Diarrhea Vaccines Market: Market Share Analysis
14.2. Porcine Epidemic Diarrhea Vaccines Distributors and Customers
14.3. Porcine Epidemic Diarrhea Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CAVAC
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Green Cross Veterinary Products
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Harrisvaccines, Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Komipharm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nisseiken Co., Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Qilu Animal Health
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Zoetis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
